Ventricular Assist Devices Market Report 2021: Latest Trends, Top Manufacturers, Product Type, End User, Impact Due to COVID-19 and Forecast 2027
A comprehensive overview of the Ventricular Assist Devices Market is recently added by UnivDatos Market Insights to its humongous database. The ventricular assist devices market report has been aggregated by collecting informative data from various dynamics such as market drivers, restraints, and opportunities. This innovative report makes use of several analyses to get a closer outlook on the ventricular assist devices market. The ventricular assist devices market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. Furthermore, this statistical market research repository examines and estimates the ventricular assist devices market at the global and regional levels. The Global Ventricular Assist Devices Market is expected to grow significantly by 2027.
Market Overview
Calon Cardio-Technology
Ltd. a UK-based company aspires to get the CE Mark for its “MiniVAD” by early
2024, by this time its US FDA early feasibility study is also expected to be completed.
The company pursues to raise funds of almost US$ 47 million to US$ 60 million
to support its R&D for the MiniVAD in the US and Europe from 2020 to 2023. Moreover, the need for ventricular
assist devices is mainly rising due to the lack of heart donors which is
increasing the number of patients waiting for heart transplantation. According
to the organ donation data by the U.S. Department of Health & Human
Services, almost 107,000 men, women, and children are on the national
transplant waiting list for a lifesaving organ transplant by February
2021. Also, 17 people die each day waiting for an organ transplant.
Request Sample Copy of this Report @ https://univdatos.com/request_form/form/441
Furthermore, the Total Artificial
Heart manufacturing industries are showing advanced device innovations and are
expected to observe a rise in the number of launches and approvals. For instance, in December 2020, CARMAT an artificial heart manufacturing
company received the CE Mark. The Total Artificial Heart created by CARMAT is
self-regulated and changes the blood flow centered on the patient’s physical
activity.
COVID-19 Impact
The
COVID-19 pandemic has impacted all industries including medical devices. Most
of the market players in their cardiac rhythm management devices segments have
experienced huge losses due to the postponement of cardiovascular procedures. For
instance, Medtronic has experienced a 12% decrease in its cardiac rhythm
management devices segment in 2020, as compared to 2019. The decline was majorly
experienced in ICDs, CRT-Ds, and ventricular assist devices segments,
among others. Such factors have negatively affected the growth of the ventricular
assist device market during the COVID-19 pandemic.
Ask for Price & Discounts @ https://univdatos.com/request_form/form/441
Global Ventricular Assist Devices Market report is studied
thoroughly with several aspects that would help stakeholders in making their
decisions more curated.
By Product, the market is primarily bifurcated into
· Left ventricular assist devices
(LVADs)
· Right ventricular assist devices
(RVADs)
· Biventricular assist devices
(BIVADs)
· Percutaneous Ventricular Assist
Devices (PVADs)
· Total Artificial Heart (TAH)
The Left ventricular assist devices
(LVADs) segment generated the highest revenue in 2020 and the market is expected
to grow at a significant rate during the forecast period. It is implanted in patients with heart
failure and helps the bottom left chamber of the heart (left ventricle) pump
blood out of the ventricle to the aorta and the rest of the body.
By Application,
the market is primarily bifurcated into
· Bridge-to-candidacy (BTC) therapy
· Bridge-to-transplant (BTT)
therapy
· Bridge-to-recovery (BTR) therapy
· Others
The Destination therapy segment accounted for
the major revenue portion in 2020 and the sector is anticipated to observe
lucrative growth in the upcoming years.
By Flow, the market is primarily bifurcated into
· Pulsatile Flow
· Continuous Flow
o Axial Continuous Flow
o Centrifugal Continuous Flow
The Continuous Flow segment accounted for the major revenue portion in 2020. The sector is anticipated to observe considerable growth in
the upcoming years, owing to its smaller size, longer durability, higher
energy efficiency, less thrombogenicity, and less surgical trauma.
Ask for Report Customization @ https://univdatos.com/request_form/form/441
By Design, the market is primarily bifurcated into
· Transcutaneous
· Implantable
The Implantable segment accounted for the major revenue portion in 2020 and the sector
is anticipated to observe substantial growth during the forecast
period.
By End-user, the market is primarily bifurcated into
·
Ambulatory Surgical Centers
·
Others
The Hospitals & Cardiac Center segment is
anticipated to observe lucrative growth in 2020. As they provide superior care to their patients and offer compensations
during surgeries.
Artificial Intelligence in Drug
DiscoveryMarket Geographical Segmentation Includes:
·
North America (US, Canada, and Rest of
North America)
·
Europe (Germany, UK, Italy, France,
Spain, and Rest of Europe)
·
Asia-Pacific (China, Japan, India,
Australia, and
Rest of Asia-Pacific)
·
Rest of the World
Based
on the estimation, North America constitutes a major market for the ventricular
assist devices industry and generated maximum revenue in
2020 owing to the presence of major companies and
healthcare infrastructure with the highest rate of cardiovascular diseases
across the world.
The
major players targeting the market includes
·
Medtronic PLC
·
Abbott Laboratories
·
Berlin Heart GmbH
·
Reliant Heart Inc.
·
Abiomed Inc.
·
Terumo Corporation
·
Angiodroid
·
SynCardia Systems
·
CardiacAssist, Inc.
·
Getinge
Competitive Landscape
The degree of competition among prominent global companies has been
elaborated by analyzing several leading key players operating worldwide. The
specialist team of research analysts sheds light on various traits such as
global market competition, market share, most recent industry advancements,
innovative product launches, partnerships, mergers, or acquisitions by leading
companies in the ventricular assist devices market. The major players have been
analyzed by using research methodologies for getting insight views on global
competition.
For more informative
information, please visit us @ https://univdatos.com/request_form/form/441
Key questions resolved through this
analytical market research report include:
•
What are the latest trends, new
patterns, and technological advancements in the ventricular assist devices market?
•
Which factors are influencing
the ventricular assist devices market over the forecast period?
•
What are the global challenges,
threats, and risks in the ventricular assist devices market?
•
Which factors are propelling
and restraining the ventricular assist devices market?
•
What are the demanding global
regions of the ventricular assist devices market?
•
What will be the global market
size in the upcoming years?
•
What are the crucial market
acquisition strategies and policies applied by global companies?
We understand the requirement of different businesses, regions, and
countries, we offer customized reports as per your requirements of business
nature and geography. Please let us know If you have any custom needs.
UnivDatos
Market Insights (UMI), is a passionate market research firm and a subsidiary of
Universal Data Solutions. Rigorous secondary and primary research on the market
is our USP, hence information presented in our reports is based on facts and
realistic assumptions. We have worked with 200+ global clients, including some
of the fortune 500 companies. Our clientele praises us for quality of insights,
In-depth analysis, custom research abilities and detailed market segmentation.
Contact us:
UnivDatos
Market Insights (UMI)
Email:
sales@univdatos.com
Ph: +91
7838604911
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home